ADAC Laboratories claimed at the RSNA meeting last month to havegrown from the third-largest supplier of SPECT cameras in theU.S. to first place in 1991. According to ADAC's analysis of theU.S. SPECT market, the top camera suppliers after itself are
ADAC Laboratories claimed at the RSNA meeting last month to havegrown from the third-largest supplier of SPECT cameras in theU.S. to first place in 1991. According to ADAC's analysis of theU.S. SPECT market, the top camera suppliers after itself are GE,Siemens and Picker.
Picker, which acquired independent SPECT vendor Ohio Imagingtwo years ago (SCAN 9/13/89), also saw its market position grow,while GE and Siemens were down, according to ADAC.
This analysis may not indicate future trends, however, sinceboth GE and Siemens were relative latecomers to the growing multidetectorSPECT niche. Both firms introduced their first multihead camerasat the 1991 Society of Nuclear Medicine meeting in Cincinnati.
ADAC saw its nuclear medicine sales decline in 1990 from theirhigh point in 1989 but recovered position last year.
"Perhaps the market's best kept secret is that ADAC isnow the leading supplier of SPECT cameras in the U.S.," saidpresident Stanley Czerwinski. "This is quite a change fromwhere we were in 1989 and especially from 1990, when we were atbest number three."
The nuclear medicine market received a boost from increaseduse of the modality in screening for more expensive interventionalprocedures. Much of this activity has been in cardiac applications,he said.
"Cardiac studies are now the largest application in nuclearmedicine in the U.S., accounting for almost 40%," Czerwinskisaid. "Bone, lung and gastric studies have remained constantfor the last couple of years. They represent another 40% of themarket. Despite the constant talk of threats of incursion by othermodalities, nuclear medicine continues to flourish because ofits value."
The second market dynamic in nuclear medicine is the increaseduse of multihead cameras, largely at the expense of single-detectorsystems. Multihead systems have grown from less than 10% of theU.S. SPECT market to more than 25% over the last two years, hesaid.
"The reason for this is that the multihead (camera) hasthe ability to provide superior performance in the top applicationsof cardiac, bone and lung (imaging)," Czerwinski said.
BRIEFLY NOTED:
Worldwide, Toshiba retains a dominant (19%) market positionin 1990, largely through its full-line ultrasound sales in Japanand Europe. U.S. leaders Acuson, ATL and Hewlett-Packard followin a second tier, with worldwide market shares hovering around14% for each vendor (see chart).
Leading multimodality vendors GE and Siemens--including Siemen'sQuantum ultrasound subsidiary purchased in early 1990--held 3.8%and 4.2% of the ultrasound market, respectively.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.